1. Home
  2. FBIO vs NSPR Comparison

FBIO vs NSPR Comparison

Compare FBIO & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.57

Market Cap

88.7M

Sector

Health Care

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$1.99

Market Cap

81.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIO
NSPR
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
81.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FBIO
NSPR
Price
$3.57
$1.99
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$16.50
$4.00
AVG Volume (30 Days)
500.8K
86.0K
Earning Date
11-14-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,303,000.00
$7,779,000.00
Revenue This Year
$29.71
$22.76
Revenue Next Year
$49.34
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.04
52 Week Low
$1.33
$1.59
52 Week High
$4.20
$3.80

Technical Indicators

Market Signals
Indicator
FBIO
NSPR
Relative Strength Index (RSI) 70.88 50.26
Support Level $3.31 $1.88
Resistance Level $3.75 $2.07
Average True Range (ATR) 0.22 0.12
MACD 0.08 0.02
Stochastic Oscillator 84.19 68.88

Price Performance

Historical Comparison
FBIO
NSPR

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: